Why the study?
Does aggressive therapy including pleuropericardial window improve survival in patients with disseminated breast cancer and cardiac tamponade?
Population
6 patients with disseminated breast cancer and cardiac tamponade
Design
Case_series
Follow-up
up to 50 months
Authors
Loading...
May support aggressive intervention in select cases; leaves open whether pleuropericardial window improves survival in larger cohorts.
Does aggressive therapy including pleuropericardial window improve survival in patients with disseminated breast cancer and cardiac tamponade?
Aggressive therapy with a pleuropericardial window in patients with cardiac tamponade and breast cancer can lead to prolonged survival.
Bitran et al. (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: